Aller au contenu

Publications scientifiques

  • article De Serres-Bérard T, Pouliot V, Puymirat J, Chahine M

    Generation of a control induced pluripotent stem cell line (CBRCULi014-A) derived from the lymphoblastoid cells of a pediatric individual

    Stem Cell Res 81 2024.

    DOI PUBMED
  • article Cupelli M, Ginjupalli VKM, Reisqs JB, Sleiman Y, El-Sherif N, Gourdon G, Puymirat J, Chahine M, Boutjdir M

    Calcium handling abnormalities increase arrhythmia susceptibility in DMSXL myotonic dystrophy type 1 mice

    Biomed Pharmacother 180 2024.

    DOI PUBMED
  • article Pierre M, Jauvin D, Puymirat J, Boutjdir M, Chahine M

    Generation of three myotonic dystrophy type 1 patient iPSC lines (CBRCULi018-A, CBRCULi019-A, CBRCULi020-A) derived from lymphoblastoid cell lines for disease modelling and ther…

    Stem Cell Res 76 2024.

    DOI PUBMED
  • article De Serres-Bérard T, Jauvin D, Pouliot V, Puymirat J, Chahine M

    Generation of a lymphoblastoid-derived induced pluripotent stem cell line (CBRCULi015-A) from a patient with congenital myotonic dystrophy

    Stem Cell Res 77 2024.

    DOI PUBMED
  • article Ginjupalli VKM, Cupelli M, Reisqs JB, Sleiman Y, El-Sherif N, Gourdon G, Puymirat J, Chahine M, Boutjdir M

    Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1

    Front Physiol 14 2023.

    DOI PUBMED
  • article Morales F, Corrales E, Vásquez M, Zhang B, Fernández H, Alvarado F, Cortés S, Santamaría-Ulloa C, Initiative-Mmdbdi MMDBD, Krahe R, Monckton DG

    Individual-specific levels of CTG•CAG somatic instability are shared across multiple tissues in myotonic dystrophy type 1

    Hum Mol Genet 32 (4), 2023.

    DOI PUBMED
  • article De Serres-Bérard T, Jauvin D, Puymirat J, Chahine M

    Generation of induced pluripotent stem cell lines from pediatric patients with congenital myotonic dystrophy (CBRCULi012-A and CBRCULi013-A) and age-matched controls (CBRCULi010…

    Stem Cell Res 72 2023.

    DOI PUBMED
  • article Pierre M, Djemai M, Chapotte-Baldacci CA, Pouliot V, Puymirat J, Boutjdir M, Chahine M

    Cardiac involvement in patient-specific induced pluripotent stem cells of myotonic dystrophy type 1: unveiling the impact of voltage-gated sodium channels

    Front Physiol 14 2023.

    DOI PUBMED
  • article Chahine M, Jauvin D, Pierre M, Puymirat J, Boutjdir M

    Lymphoblastoid cell lines derived from iPSCs of a myotonic dystrophy type 1 patient carrying 700 CTG repeats (CBRCULi007-A) and a control (CBRCULi006-A)

    Stem Cell Res 71 2023.

    DOI PUBMED
  • article Jauvin D, Pierre M, Boutjdir M, Puymirat J, Chahine M

    Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoid…

    Stem Cell Res 67 2023.

    DOI PUBMED
  • article Ait Benichou S, Jauvin D, De Serres-Bérard T, Pierre M, Ling KK, Bennett CF, Rigo F, Gourdon G, Chahine M, Puymirat J

    Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

    Gene Ther 29 (12), 2022.

    DOI PUBMED
  • article De Serres-Bérard T, Ait Benichou S, Jauvin D, Boutjdir M, Puymirat J, Chahine M

    Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1

    Int J Mol Sci 23 (21), 2022.

    DOI PUBMED